← All Sponsors

SPONSOR

Nested Therapeutics, Inc

Total Trials

1

Recruiting

1

Phases

Phase 1

Conditions studied: Oncology MEK Mutation RAF Gene Mutation Ras (KRAS or NRAS) Gene Mutation Melanoma NSCLC Glioma Solid Tumor, Adult MAPK Pathway Gene Mutation

NCT06326411 Phase 1

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors